NOV 06, 2019 1:30 PM PST

Impact of the cobas Liat® Flu Assay on Clinical Decision Making in the Emergency Department Setting (Clade Study Group)

Presented at: Influenza 2019
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor, Division of Infectious Diseases, Department of Pathology & Laboratory Medicine, University of Minnesota, and Director of Clinical Microbiology, Hennepin Medical Center
    Biography
      Dr. Glen Hansen is an Assistant Professor of Medicine in the Division of Infectious Diseases and the department of Pathology & Laboratory Medicine at University of Minnesota. He is the medical director for the clinical microbiology and molecular diagnostics laboratory at Hennepin County Medical Center HCMC The Clinical Microbiology laboratory is a full-service microbiology including areas of virology, mycology, mycobacteriology, bacteriology, parasitology and molecular diagnostics. He graduated from The University of Saskatchewan and Royal University hospital with a PhD in clinical microbiology. He has formal fellowship training in molecular diagnostics from New York Public Health Research Institute (PHRI) and clinical and medical microbiology from the University of Washington. He is the former director of microbiology and molecular Diagnostics at Oregon Medical/Peace Health laboratories in Eugene Oregon and has been the director of microbiology and molecular diagnostics at HCMC since 2006.

    Abstract

    Respiratory viral infections remain a leading cause of medical visits and can contribute significantly to morbidity and mortality. Influenza, together with pneumonia, is the leading infectious cause of death in Canada and the United States, and is of particular concern especially in individuals with secondary risk factors. As "influenza season" approaches each year, hospitals and healthcare organizations review and update testing algorithms in attempts to maximize clinical useful testing, staffing issues, sensitivity, and rising health care costs. Despite decades of diagnostic research into laboratory and clinic based influenza testing, no one single diagnostic algorithm has emerged as a one size-fits-all strategy. Clinical decision making and subsequent patient management for patients who present to busy emergency departments during flu season is not always straight forward. Recently the COBAS LIAT Influenza assay was recently approved by the FDA for diagnosis of Influenza A/B virus. The test represents among the first truly rapid multiplex molecular PCR-based assays that can simultaneously detect and discriminate influenza A and influenza B RNA in nasopharyngeal specimens. While the prospects of reliable rapid influenza diagnostics have been examined before, few studies have attempted to correlate in real time the immediate impact of influenza assays, and no study assessing the clinical utility of LIAT during influenza season has been performed to date. Objectives: 1. Introduce the historical challenges of test options for influenza testing in hospital settings 2. Describe the performance and test characteristics of the Cobas® Liat influenza A/B assay on emergency department patients who presented with influenza-like-illness during the 2015 influenza season 3. Demonstrate the impact that rapid reliable influenza testing within emergency department settings have on patient management


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 06, 2019 1:30 PM PST

    Impact of the cobas Liat® Flu Assay on Clinical Decision Making in the Emergency Department Setting (Clade Study Group)

    Presented at: Influenza 2019
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Molecular Biology

    Clinical Diagnostics

    Laboratory Testing

    Immunology

    Molecular Diagnostics

    Biochemistry

    Gene Expression

    Diagnostics

    Microbiology

    Animal Research

    Pcr/rt-Pcr/real-Time Pcr

    Infectious Disease

    Biotechnology

    Cell Biology

    Antibodies

    Geography

    North America64%

    Asia36%

    Registration Source

    Website Visitors86%

    Email Promotions14%

    Job Title

    Medical Laboratory Technician42%

    Educator/Faculty17%

    Veterinarian17%

    Clinical Laboratory Scientist8%

    Research Scientist8%

    Scientist8%

    Organization

    Academic Institution29%

    Clinical Laboratory21%

    Veterinary School14%

    Hospital14%

    Medical School7%

    Medical Center7%

    Biotech Company7%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more